PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of blackwellopenThis ArticleFor AuthorsLearn MoreSubmit
Aging Cell
 
Aging Cell. 2009 February; 8(1): 18–25.
PMCID: PMC2667647

B-cell diversity decreases in old age and is correlated with poor health status

Abstract

Older people suffer from a decline in immune system, which affects their ability to respond to infections and to raise efficient responses to vaccines. Effective and specific antibodies in responses from older individuals are decreased in favour of non-specific antibody production. We investigated the B-cell repertoire in DNA samples from peripheral blood of individuals aged 86–94 years, and a control group aged 19–54 years, using spectratype analysis of the IGHV complementarity determining region (CDR)3. We found that a proportion of older individuals had a dramatic collapse in their B-cell repertoire diversity. Sequencing of polymerase chain reaction products from a selection of samples indicated that this loss of diversity was characterized by clonal expansions of B cells in vivo. Statistical analysis of the spectratypes enabled objective comparisons and showed that loss of diversity correlated very strongly with the general health status of the individuals; a distorted spectratype can be used to predict frailty. Correlations with survival and vitamin B12 status were also seen. We conclude that B-cell diversity can decrease dramatically with age and may have important implications for the immune health of older people. B-cell immune frailty is also a marker of general frailty.

Keywords: aging, B cells, diversity, elderly, immune frailty

Introduction

Older people suffer from a decline in the immune system that affects their ability to respond to infections and to raise effective responses to vaccines (Weinberger et al., 2008). This is particularly apparent from the high mortality rates due to pneumonia in the elderly (Office for National Statistics, 2005), and their susceptibility to hospital-acquired infections, such as Clostridium difficile and methicillin-resistant Staphylococcus aureus (Health Protection Agency, 2008). Many aspects of the immune system are altered in immunosenescence. The T-cell repertoire is decreased, T cells lose responsiveness (Effros et al., 2003; Koch et al., 2006), macrophages have a decreased antigen-presenting capacity and altered cytokine secretion (Dace & Apte, 2008), follicular dendritic cells cannot present antigen as efficiently (Aydar et al., 2004), and neutrophils lose phagocytic ability (Lord et al., 2001). The humoral immune system is crucial to the effective response against bacterial infections such as pneumonia, but its role in immune frailty has not been well studied. It is known that the quality of the antibody response changes with age, with a lower level of specific antibodies and an increased level of non-specific antibodies being generated in response to vaccination (Howard et al., 2006). The reasons for this failure, and the increased susceptibility to bacterial infections, remain to be fully elucidated, but it seems likely that changes in the humoral immune system would play a key role in the increased immune frailty of the elderly.

High-affinity specific antibodies are generated during affinity maturation, a process that takes place in the germinal centre of secondary lymphoid tissue and is characterized by somatic hypermutation of Ig genes and subsequent selection of the genes encoding the best antibodies (MacLennan, 1994). There have been reports of an increased level of mutations in Ig genes in older people (Dunn-Walters et al., 1997; Chong et al., 2003). However, we have shown that the somatic hypermutation process occurs at the same rate in young and old humans, and so this difference is more likely a consequence of accumulation rather than altered rate (Banerjee et al., 2002). We have also found that the imprint of hypermutation, in terms of the types of mutations and the hotspots in which they occur, is the same in samples from both young and elderly individuals, suggesting that the mechanism of hypermutation does not change with age (data not shown). Finally, data from our study (Banerjee et al., 2000) and that of others (Lazuardi et al., 2005) provide no evidence for age-related changes in the size and number of germinal centres in humans, although the situation may be somewhat different in mice (Zheng et al., 1997).

Although the most well-known function of B cells is as antibody producers, they have intrinsic properties that also make a vital contribution to the immune system. They are highly effective as antigen-presenting cells, and have been shown to be essential for the development of T-cell memory (Crawford et al., 2006). There is also now substantial evidence to support their role as immune regulators, since they are capable of secreting IL10. IL10-secreting B cells could serve to prevent inappropriate stimulation of the immune system, such as that leading to autoimmune disease, and could also serve to limit the aggressiveness of bona fide immune responses (Fillatreau et al., 2008). It thereby follows that a loss of diversity in the B-cell repertoire would be predicted to have dramatic and serious consequences for the integrity of the humoral immune system. To date there has been a paucity of evidence regarding changes in the B-cell repertoire with age. Some contradictory studies have concentrated on determining whether there is a change in the relative proportions of the different IGHV gene families with age (Van Dijk-Hard et al., 1997; Wang & Stollar, 1999), but since there are only six different IGHV families, and an estimated 108 B cells per person, this method of assessing diversity is less than ideal. Studies focussing on sequencing the area of the hypervariable complementarity determining three (CDR3) region of the IGH gene, an area highly important for antigen binding, have been limited by the logistics of large-scale sequencing and so have been restricted to small numbers of individuals and only one subgroup of Ig genes (Xue et al., 1997; Kolar et al., 2006). Because these and other previous studies were restricted in their ability to measure diversity, we therefore set out to undertake a comprehensive analysis of B-cell diversity in the elderly, using as our technique the CDR3 spectratyping of all IGH genes. The CDR3 region of the Ig heavy chain gene comprises the area where three different Ig genes (IGHV, IGHD, IGHJ) join together to make the whole. As such it is highly diverse, both in sequence and in the length of the sequence. Amplifying the CDR3 region of the Ig gene using labelled primers and running the subsequent products on a high-resolution sequencing gel produces a characteristic spectratype, representing the distribution of different CDR3 sizes in the sample population. For our study population, we used peripheral blood mononuclear cell samples taken from older people in the Swedish NONA longitudinal study on immunosenescence. This study, and its predecessor (OCTO study), followed the health and T-cell immune characteristics of a number of old volunteers and resulted in the discovery of a T-cell ‘Immune Risk Phenotype’ (IRP) that predicted mortality in the very old. IRP is characterized by an expansion of CD8+ T cells, and a resulting inverted CD4+/CD8+ ratio (Wikby et al., 1998, 2002). Later studies on the same patient group showed that inflammatory markers, such as IL-6, CRP and albumin, are also significant predictors of mortality in very old humans (Wikby et al., 2006). Using an objective measurement of our B-cell spectratypes as a measure of B-cell diversity, together with additional direct sequence data, our data revealed a striking collapse in B-cell diversity in a subset of older individuals in this study that is not seen in our control samples from young, healthy individuals. Furthermore, this collapse in B-cell diversity is a biomarker that is strongly predictive of poor health status (frail vs. healthy) in the NONA cohort, as well as the likelihood of death within the next 4-year interval. Overall these data reveal a hitherto unexpected collapse in the humoral immune system with age in some elderly individuals, with significant implications for their ability to defend against pathogens and respond to vaccination.

Results

B-cell diversity can dramatically collapse in some older individuals

We investigated the diversity of the peripheral blood B-cell population in older people using spectratype size analysis of the IGH CDR3 region (Fig. 1a). A polyclonal B-cell population from a healthy young individual typically yields a spectratype of CDR3 lengths in the range 57–117 bp that follows an approximately normal distribution (top panel in Fig. 1b,c). Although many individuals in the Swedish longitudinal NONA cohort also show a similar normally distributed spectratype, we observed several samples where the spectratype was strikingly and reproducibly non-normal (third and fourth panels in Fig. 1b,c), often due to the presence of one or more unusually abundant fragment lengths.

Fig. 1
Generation of B-cell spectratypes from peripheral blood mononuclear cells. (a) Seminested PCR is performed over the CDR3 region (IGHV-IGHD-IGHJ joining region of the immunoglobulin heavy chain gene), the positions of the primers are indicated by the black ...

To compare multiple spectratypes, the fragment size and peak height of the initial ABI 377 spectratype data were quantified, which enable the data to be summarized in graphical format (Fig. 1c). Using this summarization technique we compared data from blood samples from a younger control group (28 people, 19–55 years old) with samples from 45 participants of the NONA study (aged 86, 90 and 94 years). The shape of the spectratypes varied much more in the older population than in the younger control group, as can be clearly seen when all the data are overlayed (Fig. 2a,b).

Fig. 2
Age effects on B-cell spectratypes. The line plots for B-cell spectratypes from peripheral blood mononuclear cells of 24 young (a, aged 19–55 years) and 32 old (b, aged 86–94 years) donors are overlaid to show the increased deviation from ...

The presence of peaks of altered height in such spectratypes distorts the fragment distribution away from a normal (Gaussian) distribution, such as that seen in the young samples. A number of parameters could be used to explore these distributional changes, including skew and kurtosis, or the correlation to a normal distribution. However, a simple metric that is sensitive to these distortions is the standard deviation (SD) of the distribution. This decreases in instances (such as the bottom panels in Fig. 1b,c) where there is increased peak height in fragments close to the centre point of the distribution, and increases in those cases when the peak height increases are in fragment lengths that are towards the edge of the range. When plotted vs. age, it is striking that whereas the mean of the SDs of both the young and NONA samples are approximately equal, the latter show a significantly wider spread of SD values (Fig. 2c).

The simplest hypothesis is that the altered peak heights in a distorted spectratype represent reduced B-cell diversity, together with possible oligoclonal expansions in the B-cell repertoire. To test this we chose six samples from older individuals for further investigation, two of which had a spectratype of approximately normal appearance and four that deviated markedly from a normal distribution. Polymerase chain reaction (PCR) products from these samples were sequenced in order to more closely examine the diversity of the population (Fig. 3). In the samples that showed distorted (non-normal) spectratypes, we observed multiple independent identical, or near-identical, sequences (Fig. 3). In addition there are some sequences that have the same V-D-J rearrangement but show individual nucleotide differences; these differences are due to in vivo somatic hypermutation events since the observed level of hypermutation is far higher than the experimentally determined PCR error rate for these methods (Dunn-Walters et al., 1995). These duplicates thus represent in vivo clonal expansions of an individual B-cell family, and overall these data provide strong evidence for oligoclonality (and thus a collapse in B-cell diversity) in those samples with spectratypes of non-normal appearance.

Fig. 3
Clonal expansions of B cells in samples with distorted spectratypes, but not in samples with normal spectratypes. The CDR3 regions, covering the IGHV-IGHD-IGHJ joining regions of the immunoglobulin heavy chain gene, were cloned and sequenced from six ...

The extent of loss in B-cell diversity correlates with health status in the elderly

The results presented above indicated that many of the NONA individuals had distorted spectratypes whose SD was smaller, or larger, than that generally seen for the young population (Fig. 2c). To further explore our data we superimposed the health status of each individual upon a plot of the SDs of the NONA samples (Fig. 4). Initial visualization revealed that those spectratypes whose SD values were atypically low or high when compared to the mean SD for the control group were also the samples from volunteers that had been classified as frail at the time of sampling (Wikby et al., 2002), whereas those classified as healthy, or very healthy, generally had spectratype SD values closer to the mean SD of the control group spectratypes (Fig. 4a). This effect was seen for each of the three older age groups individually (Fig. 4b).

Fig. 4
Visualization of the relationship between health status and spectratype SD. The SD of each spectratype was calculated as the measure of its distortion and then plotted vs. mean fragment length for ease of visualization (a). Each point is labelled according ...

To provide a single metric that is linearly related to this degree of deviation from the expected SD, we therefore calculated the difference (in absolute terms) between the sample SD and the mean SD of the control group spectratypes. This metric, referred to as ΔSD, provides a singal value reflecting the degree of distortion of a spectratype and thus diversity, with high values associated with restricted diversity. Fig. 5(a) provides a different summarization of Fig. 4, and demonstrates that an elevated ΔSD value is associated with frailty. The difference between the frail group and the others is highly significant [p < 0.0001 by Mann–Whitney U-test (MWU)]. The ΔSD value is predictive of fraility, with ΔSD of greater than 1 predicting frailty with a sensitivity of 0.78 and a specificity of 0.92 [as determined by receiver operating characteristic (ROC) curve analysis].

Fig. 5
Correlations with health and survival. The ΔSD value for each sample was determined as being the difference between the sample value and the mean control value. Donors had previously been classified as frail (f), healthy (h) or very healthy (vh) ...

Finally, since the blood samples had been taken several years previously, it was possible to utilize follow-up data on survival of the donors. This revealed that there was also a significant difference in ΔSD between those that survived longer than 4 years and those that died within 3 years after donating the sample for analysis (p < 0.05 by MWU, Fig. 5b). The medical history was available for these individuals and we also found an association between vitamin B12 deficiency and ΔSD (p < 0.05 by MWU, Fig. 5c). There were no other associations that reached significance.

Discussion

We have shown that we can measure B-cell diversity from peripheral blood samples by a relatively simple method of PCR and analysis of the resulting spectratype. Some very old individuals show a dramatic reduction in B-cell diversity and this is linked to frailty.

The link between the general health status of the individuals in this study and their B-cell diversity is quite striking. Since the general classification of ‘healthy’ was that the volunteers were not medicated, institutionalized or demented (Wikbyet al., 2002), the definition of ‘frail’ in this instance goes well beyond just immune frailty and susceptibility to infections. Thus, a collapse in B-cell diversity seems to be a marker of overall frailty rather than being specifically related to immune frailty. The complexity of old age health makes it difficult to determine whether the loss of B-cell diversity is a cause of frailty, or is a consequence of a decline in health from other causes. With subjects of such old age the medical histories could be quite complex, with co-morbidity being a common occurrence. However, with the exception of vitamin B12 deficiency, there were no significant associations between ΔSD and any particular illness. There was a significant difference in ΔSD between those patients who were deficient in vitamin B12 and the others (p = 0.026 by MWU). This may be of relevance since vitamin B12 deficiency can result in leucopenia (Andrès et al., 2006). Since many old people are vitamin B12 deficient, and supplementation is a relatively simple treatment, it is important to elucidate the relevance of this finding. Further studies would be needed to determine whether there is a causative link between vitamin B12 deficiency and loss of B-cell diversity, and whether leucocyte diversity can be improved by restoration of normal vitamin B12 levels.

A reduced B-cell diversity is hypothesized to occur if the bone marrow output of new cells is reduced. Since the overall number of B cells does not change, reduced input of new B cells would result in a greater proportion of antigen-experienced cells in the population. The nature of a B-cell response, where the B-cell population with receptor specific for antigen expands, means that a repertoire made up of more antigen-experienced cells would be expected to show evidence of clonality. This would be evident in spectratypes, since expansion of one particular B-cell clone means expansion of a particular size of CDR3 region. To confirm this hypothesis, we sequenced the CDR3 regions from a selection of samples and showed that we did indeed see evidence of clonally related cells in cases where the spectratype was distorted, but not in cases where the spectratype was normally distributed. It is not known whether bone marrow output of B cells is reduced in old age in humans, but it has been shown for mice (Cancro, 2005). It has also been shown that, both in mice and humans, the proportion of memory B cells increases with age (Williams et al., 2000; Macallan et al., 2005; Colonna-Romano et al., 2006).

An alternative explanation for seeing distorted spectratypes of B cells is of pathological expansions of B cells, such as are seen in leukaemia/lymphoma/monoclonal gammopathy. Individuals with such a diagnosis were not included in this study; however, the PCR method was originally developed as a sensitive test for leukaemia or lymphoma and therefore we may pick up pre-clinical conditions. An increase in monoclonal expansions of B cells, both of CD5+ and CD5 phenotype, has previously been reported in older people (Ghia et al., 2004). Monoclonal gammopathy of undetermined significance (MGUS) is a predominant plasma-cell disorder, is characterized by an increase in presence of serum monoclonal Ig, and has been shown to increase with age (Ligthart et al., 1990; Kyle et al., 2006). Since our cohort is very old, it is possible that MGUS accounts for some of the observed repertoire restriction with increasing age. However, our data do not suggest a high prevalence of such monoclonal expansions, the restricted repertoires that we see have a more oligoclonal appearance.

There was some correlation between our measures of B-cell diversity and the IRP status of the subjects; of the seven subjects classified as IRP positive, six had a ΔSD greater than 1. However, the ΔSD appears to be a stronger predictor of health status than IRP in this study. Six out of seven IRP-positive subjects were classified as frail as compared with 13 out of 14 subjects with a ΔSD greater than 1 being classified as frail (confirmed by ROC curve analysis, data not shown).

One immediate question arising from these findings is whether a reduced B-cell diversity affects the ability of the immune system to respond to challenge. We are commencing a study to determine whether the quality of response to vaccination is related to B-cell diversity. Since this method of analysis is relatively simple, we could envisage its future use as a predictor of the quality of response to vaccines in older people, thus enabling the identification of poor responders so that alternative healthcare strategies can be considered.

Experimental procedures

Blood samples from cadaver donors, whose relatives had given permission for general research use, were collected as part of the normal tissue typing laboratory sampling procedures at Guy's Hospital, London, UK. Blood samples from old volunteers were previously collected as part of the Swedish NONA–Immune longitudinal study (Wikby et al., 2002). Consent was obtained according to the guidelines of the ethics committee of Linköping University, Sweden.

DNA was extracted from peripheral blood mononuclear cells using the QIAamp DNA blood mini kit (Qiagen, Crawley, UK) and used at a concentration of approximately 100 ng µL−1 in PCRs. The CDR3 region of the rearranged IGH gene (Fig. 1a) was amplified by adding 2 µL of sample in a total volume of 25 µL using two rounds of PCR in a seminested fashion (Diss et al., 1993) with the following primers: Fw3 region 5′ primer, 5′-ACACGGCTGTGTATTACTGT-3′, IGHJ region 3′ primer 1, 5′-ACCTGAGGAGACGGTGACCAGGGT-3’, IGHJ region 3′ primer 2, 5′-GTGACCAGGGTTCCTTGGCCCCAG-3′. The 3′ nested J region primer 2 was labelled with the fluorescent marker 6-Fam. PCR products were prepared for loading by adding 2 µL of blue loading dye, containing formamide, and 1 µL of 1 : 2 diluted size standard (350-TAMRA; Applied Biosystems, Warrington, UK) to 1 µL of PCR product. Tubes were heated to 95–100 °C for between 2 and 5 min and then placed onto ice to denature the DNA. The samples were run on a 6% denaturing polyacrylamide slab sequencing gel on the ABI 377, according to manufacturer's instructions (Applied Biosystems). The results were saved to file and analysed using GeneScan (Applied Biosystems) to determine the peak sizes for each main peak in the spectratype. Since the sequencing gel resolves to 1 bp, but the main peaks are every 3 bp (reflecting the predominance of open reading frame rearrangements of IGH), we took the values for the peaks at 3-bp intervals for further analysis. These values were copied into Microsoft Excel files which were imported and analysed further in the R statistical programming environment (http://www.r-project.org, R Development Core Team, 2006) to determine the standard deviation of the spectratypes, calculate MWU values, and perform ROC curve analysis. We have illustrated our findings here using the standard deviation as the metric to summarize the distributional distortions because it makes no assumptions regarding the underlying distribution. However, broadly similar conclusions were obtained when using skew, kurtosis or a direct measure of correlation to normality as the summarization metric (data not shown).

CDR3 PCR products from some of the spectratypes were sequenced by LGC Agowa sequencing services after first subcloning into the p-GEM®-T easy plasmid vector according to manufacturer's instructions (Promega, Southampton, UK). Sequences were analysed to identify IGHD and IGHJ usage and aligned using IMGT V-quest (Brochet et al., 2008) and MegAlign software (from the DNAStar software suite, Lasergene, Madison, Wisconsin, USA).

Acknowledgments

This work was funded by the Dunhill Medical Trust, the Human Frontiers Science Program, the EU project ‘T cell immunity and aging’, T-CIA, contract no (QLK6-CT-2001-02283) and the Medical Reseach Council of South-eastern Sweden. We also gratefully acknowledge Länssjukhuset Ryhov for providing laboratory resources for completion of the studies in Sweden.

References

  • Andrès E, Affenberger S, Zimmer J, Vinzio S, Grosu D, Pistol G, Maloisel F, Weitten T, Kaltenbach G, Blicklé JF. Current hematological findings in cobalamin deficiency. Clin. Lab. Haematol. 2006;28:50–56. A study of 201 consecutive patients with documented cobalamin deficiency. [PubMed]
  • Aydar Y, Balogh P, Tew JG, Szakal AK. Follicular dendritic cells in aging, a ‘bottle-neck’ in the humoral immune response. Ageing Res. Rev. 2004;3:15–29. [PubMed]
  • Banerjee M, Sanderson JD, Spencer J, Dunn-Walters DK. Immunohistochemical analysis of ageing human B and T cell populations reveals an age-related decline of CD8 T cells in spleen but not gut-associated lymphoid tissue (GALT) Mech. Ageing Dev. 2000;115:85–99. [PubMed]
  • Banerjee M, Mehr R, Belelovsky A, Spencer J, Dunn-Walters DK. Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees. Eur. J. Immunol. 2002;32:1947–1957. [PubMed]
  • Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36:W503–W508. [PMC free article] [PubMed]
  • Cancro MP. B cells and aging: gauging the interplay of generative, selective, and homeostatic events. Immunol. Rev. 2005;205:48–59. [PubMed]
  • Chong Y, Ikematsu H, Yamaji K, Nishimura M, Kashiwagi S, Hayashi J. Age-related accumulation of Ig VH gene somatic mutations in peripheral B cells from aged humans. Clin. Exp. Immunol. 2003;133:59–66. [PubMed]
  • Colonna-Romano G, Aquino A, Bulati M, Aquino A, Vitello S, Lio D, Candore G, Caruso C. Memory B cell subpopulations in the aged. Rejuvenation Res. 2006;9:149–152. [PubMed]
  • Crawford A, Macleod M, Schumacher T, Corlett L, Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 2006;176:3498–3506. [PubMed]
  • Dace DS, Apte RS. Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res. 2008;11:177–185. [PubMed]
  • Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J. Pathol. 1993;169:291–295. [PubMed]
  • Dunn-Walters DK, Howe CJ, Isaacson PG, Spencer J. Location and sequence of rearranged immunoglobulin genes in human thymus. Eur. J. Immunol. 1995;25:513–519. [PubMed]
  • Dunn-Walters DK, Boursier L, Spencer J. Hypermutation, diversity and dissemination of human intestinal lamina propria plasma cells. Eur. J. Immunol. 1997;27:2959–2964. [PubMed]
  • Effros RB, Cai Z, Linton PJ. CD8 T cells and aging. Crit. Rev. Immunol. 2003;23:45–64. [PubMed]
  • Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 2008;8:391–397. [PubMed]
  • Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, Caligaris-Cappio F. Monoclonal CD5+ and CD5 B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103:2337–2342. [PubMed]
  • Health Protection Agency – Centre for Infections. Surveillance of Healthcare Associated Infections Report. 2008. [accessed on 20 Nov 2008]. [WWW document]. URL http://www.hpa.org.uk/web/hpawebfile/hpaweb_c/1216193833496.
  • Howard WA, Gibson KL, Dunn-Walters DK. Antibody quality in old age. Rejuvenation Res. 2006;9:117–125. [PubMed]
  • Koch S, Solana R, Dela Rosa O, Pawelec G. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech. Ageing Dev. 2006;127:538–443. [PubMed]
  • Kolar GR, Mehta D, Wilson PC, Capra JD. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand. J. Immunol. 2006;64:314–324. [PubMed]
  • Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ. Prevalence of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 2006;354:1362–1369. [PubMed]
  • Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology. 2005;114:37–43. [PubMed]
  • Ligthart GJ, Radl J, Corberand JX, Van Nieuwkoop JA, Van Staalduinen GJ, Van Helmond DJ, Hijmans W. Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech Ageing Dev. 1990;52:235–243. [PubMed]
  • Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunosenescence. Mech. Ageing Dev. 2001;122:1521–1535. [PubMed]
  • Macallan DC, Wallace DL, Zhang Y, Ghattas H, Asquith B, de Lara C, Worth A, Panayiotakopoulos G, Griffin GE, Tough DF, Beverley PC. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood. 2005;105:3633–3640. [PubMed]
  • MacLennan IC. Germinal centers. Annu. Rev. Immunol. 1994;12:117–139. [PubMed]
  • Office for National Statistics. Health Statistics Quarterly 26. 2005. [accessed on 20 Nov 2008]. [WWW document]. URL http://www.statistics.gov.uk/statbase/product.asp?vlnk=6725.
  • R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006. [accessed on 20 Nov 2008]. [WWW document]. URL http://www.r-project.org.
  • Van Dijk-Hard I, Soderstrom I, Feld S, Holmberg D, Lundkvist I. Age-related impaired affinity maturation and differential D-JH gene usage in human VH6-expressing B lymphocytes from healthy individuals. Eur. J. Immunol. 1997;27:1381–1386. [PubMed]
  • Wang X, Stollar BD. Immunoglobulin VH gene expression in human aging. Clin. Immunol. 1999;93:132–142. [PubMed]
  • Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin. Infect. Dis. 2008;46:1078–1084. [PubMed]
  • Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 1998;102:187–198. [PubMed]
  • Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 2002;37:445–453. [PubMed]
  • Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Löfgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 2006;127:695–704. [PubMed]
  • Williams GT, Jolly CJ, Kohler J, Neuberger MS. The contribution of somatic hypermutation to the diversity of serum immunoglobulin: dramatic increase with age. Immunity. 2000;13:409–417. [PubMed]
  • Xue W, Luo S, Adler WH, Schulze DH, Berman JE. Immunoglobulin heavy chain junctional diversity in young and aged humans. Hum. Immunol. 1997;57:80–92. [PubMed]
  • Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol. Rev. 1997;160:63–77. [PubMed]

Articles from Wiley-Blackwell Online Open are provided here courtesy of Wiley-Blackwell, John Wiley & Sons